Belite Bio, Inc Proceeds from Issuance of Convertible Preferred Stock
Belite Bio, Inc (BLTE) reported Proceeds from Issuance of Convertible Preferred Stock of $29.79 million for the 12-month period ending 2020-12-31, per its 20-F filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2023-03-31
| Period end | Proceeds from Issuance of Convertible Preferred Stock 12 month |
|---|---|
| 2020-12-31 | $29.79M 20-F · filed 2023-03-31 |